Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC
- Status
- COMPLETED
- Phase
- PHASE3
Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
- Status
- COMPLETED
- Phase
- PHASE3
Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic Study of Carboplatin in Pediatric Hematopoietic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status
- Status
- COMPLETED
- Phase
- PHASE2
Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC
- Status
- COMPLETED
- Phase
- PHASE2